Skip to main navigation
Skip to search
Skip to main content
Status Finished Effective start/end date 1/10/20 → 30/09/21
National Cancer Institute: $588,377.00
Genetics
Biochemistry, Genetics and Molecular Biology
100%
SLCO1B3
Biochemistry, Genetics and Molecular Biology
100%
Molecular Mechanism
Biochemistry, Genetics and Molecular Biology
100%
Prostate Cancer
Pharmacology, Toxicology and Pharmaceutical Science
100%
MicroRNA
Biochemistry, Genetics and Molecular Biology
60%
Androgen
Pharmacology, Toxicology and Pharmaceutical Science
50%
microRNA
Pharmacology, Toxicology and Pharmaceutical Science
42%
Abiraterone
Pharmacology, Toxicology and Pharmaceutical Science
42%